[Federal Register Volume 88, Number 167 (Wednesday, August 30, 2023)]
[Notices]
[Page 59928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18635]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-1053]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Customer/Partner 
Service Satisfaction Surveys

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
that a proposed collection of information has been submitted to the 
Office of Management and Budget (OMB) for review and clearance under 
the Paperwork Reduction Act of 1995.

DATES: Submit written comments (including recommendations) on the 
collection of information by September 29, 2023.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under Review--Open for Public 
Comments'' or by using the search function. The OMB control number for 
this information collection is 0910-0360. Also include the FDA docket 
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of 
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794, 
<a href="/cdn-cgi/l/email-protection#da8a889b89aebbbcbc9abcbebbf4b2b2a9f4bdb5ac"><span class="__cf_email__" data-cfemail="77272536240316111137111316591f1f0459101801">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Customer/Partner Service Satisfaction Surveys

OMB Control Number 0910-0360--Extension

    Under section 1003 of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 393), FDA is authorized to conduct research and public 
information programs about regulated products and responsibilities of 
the Agency. Executive Order 12862, entitled ``Setting Customer Service 
Standard,'' directs Federal Agencies that ``provide significant 
services directly to the public'' to ``survey customers to determine 
the kind and quality of services they want and their level of 
satisfaction with existing services.'' FDA is seeking to extend OMB 
approval to conduct customer service satisfaction surveys to implement 
Executive Order 12862. Participation in the surveys is voluntary. This 
request covers customer/partner (including State and local governments) 
service satisfaction surveys of regulated entities, such as food 
processors; cosmetic, drug, biologic, and medical device manufacturers; 
animal drugs, animal food and feed; tobacco products; and consumers and 
health professionals.
    FDA will use the information from these surveys to identify 
strengths and weaknesses in service to customers/partners and to make 
improvements. The surveys will measure timeliness, appropriateness, 
clarity, and accuracy of information, courtesy, and problem resolution 
in the context of individual programs.
    FDA estimates conducting approximately 20 customer/partner service 
satisfaction surveys per year, each requiring an average of 25 minutes 
for review and completion. We estimate respondents to these surveys to 
be between 100 and 20,000 customers/partners. Some of these surveys 
will be repeats of earlier surveys for purposes of monitoring customer/
partner service and developing long-term data. Respondents to this 
collection of information cover a broad range of stakeholders who have 
experience with certain products regulated by or services provided by 
FDA.
    In the Federal Register of April 25, 2023 (88 FR 24992), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. One comment was received in support of this 
information collection.
    FDA estimates the burden of this collection of information as 
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              Number of
                 Activity                     Number of     responses per   Total annual            Average burden per  response            Total hours
                                             respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Mail, telephone, web-based survey........          85,000               1          85,000  0.42 (25 minutes)............................          35,700
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Since the last OMB approval of this information collection request, 
FDA submitted three requests to increase the total burden hours. 
Therefore, this request for extension of OMB approval adjusts the 
number of respondents by an increase of 30,000 and the total burden 
hours by an increase of 21,950.

    Dated: August 24, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-18635 Filed 8-29-23; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>